IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study
Cheng, A. -L.1; Cornelio, G. H.2; Shen, L.3; Prince, T. J.4; Yang, T. -S.5; Chung, I. -J.6; Dai, G.7; Lin, J. -K.8; Sharma, A.9; Yeh, K. -H.1; Ma, B.10; Zaatar, A.11; Guan, Z.12; Masood, N.13; Srimuninnimit, V.14; Yau, T. Cheung15; Beier, F.16; Chatterjee, S.17; Lim, R. S. C.18
刊名ANNALS OF ONCOLOGY
2015-12-01
suppl.9页:45-46
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000367158700149
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61743
专题北京大学临床肿瘤学院
作者单位1.Taipei Vet Gen Hosp, Oncol, Taipei, Taiwan
2.All India Inst Med Sci, Oncol, New Delhi, India
3.Mt Miriam Hosp, Oncol, George Town, Malaysia
4.Aga Khan Univ Hosp, Oncol, Karachi, Pakistan
5.Mahidol Univ, Siriraj Hosp, Oncol, Bangkok 10700, Thailand
6.Merck KGaA, Global Biostat, Darmstadt, Germany
7.Merck Serono, Reg Med, Bombay, Maharashtra, India
8.Natl Univ Canc Inst, Oncol, Singapore, Singapore
9.San Juan de Dios Hosp, Oncol, Pasay City, Philippines
10.Queen Elizabeth Hosp, Oncol, Woodville, SA 5011, Australia
11.Chang Gung Mem Hosp Linkou, Oncol, Taoyuan, Taiwan
12.Natl Taiwan Univ Hosp, Oncol, Taipei, Taiwan
13.Peking Univ, Canc Hosp, Beijing Canc Hosp, Oncol, Beijing 100871, Peoples R China
14.Chonnam Natl Univ, Hwasun Hosp, Oncol, Hwasun Gun, South Korea
15.Gen Hosp Chinese Peoples Armed Police, Oncol, Beijing, Peoples R China
16.Chinese Univ Hong Kong, Prince Wales Hosp, Oncol, Hong Kong, Hong Kong, Peoples R China
17.Sun Yat Sen Univ, Oncol, Guangzhou 510275, Guangdong, Peoples R China
18.Univ Hong Kong, Queen Mary Hosp, Oncol, Hong Kong, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Cheng, A. -L.,Cornelio, G. H.,Shen, L.,et al. Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study[J]. ANNALS OF ONCOLOGY,2015,suppl.9:45-46.
APA Cheng, A. -L..,Cornelio, G. H..,Shen, L..,Prince, T. J..,Yang, T. -S..,...&Lim, R. S. C..(2015).Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study.ANNALS OF ONCOLOGY,suppl.9,45-46.
MLA Cheng, A. -L.,et al."Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study".ANNALS OF ONCOLOGY suppl.9(2015):45-46.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Cheng, A. -L.]的文章
[Cornelio, G. H.]的文章
[Shen, L.]的文章
百度学术
百度学术中相似的文章
[Cheng, A. -L.]的文章
[Cornelio, G. H.]的文章
[Shen, L.]的文章
必应学术
必应学术中相似的文章
[Cheng, A. -L.]的文章
[Cornelio, G. H.]的文章
[Shen, L.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。